- Analyst Ivan Feinseth of Tigress Financial has raised the price target for Walmart (NASDAQ: WMT) to $155.00, indicating a potential upside of 34.56%.
- The retail giant is strategically shifting towards higher-margin digital commerce and expanding into virtual healthcare through a partnership with Teladoc Health (NYSE: TDOC).
- Despite a recent stock dip, which saw shares fall 9.70%, the current valuation below the average analyst target of $137.81 is seen by some as a compelling buying opportunity.
Analyst Ivan Feinseth of Tigress Financial raises the price target for Walmart (NASDAQ: WMT) to $155.00. This new target suggests a potential upside, or increase in value, of 34.56% from the stock’s price of $115.19 at the time. Walmart is the world’s largest retailer, operating a vast network of discount stores and supercenters.
Walmart’s business strategy is shifting from traditional in-store traffic to higher-margin digital commerce. This includes its advertising, online marketplace, and membership services, which are now major contributors to operating income. In its competition with Costco (NASDAQ: COST), its Sam’s Club division is using a 150,000-member community to help develop new products, as highlighted by Business Insider.
As part of its digital growth, Walmart is expanding into virtual healthcare through a new collaboration with Teladoc Health (NYSE: TDOC). This partnership on Walmart’s Better Care Services platform gives customers access to virtual urgent care and other services. The goal is to use Walmart’s large customer base to provide more affordable healthcare options.
Despite this positive outlook, the market shows some doubt. Walmart shares recently fell 9.70% in one week to $118.54, even after the company beat revenue expectations. The stock currently trades near $118.00, which is below the average analyst price target of $137.81, implying a potential upside of about 16.80%.
This recent price drop has created what some see as a buying opportunity. As highlighted by 24/7 Wall St., the dip may be the “best buying opportunity of 2026.” The stock’s price over the past 52 weeks has moved between a low of $93.43 and a high of $135.16.
